12.4100.00% ( 0.000 )
Delay Suspended: Nov 16, 09:29:28Overview
MIRXES-B (2629)
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metaboli...
- Open
- 12.410
- High
- 12.410
- Low
- 12.410
- Prev. Close
- 12.410
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 64.050
- Volume Ratio
- 0.00
- Turnover Ratio
- --
- 52wk Low
- 12.280
- HK Mkt Cap
- 3.70B
- Market CapHKD
- 3.70B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.01
- EPSDynamic
- -1.49
- EPSStatic
- --
- BVPS
- 2.75
- P/B
- 4.51
- HK Shares
- 298.23M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 298.23M
- Min lot size
- 100
- Currency
- HKD
MIRXES-B Analyst Rating
View moreForecast & Rating
Sep 18, 2025Price forecast
HK$99.98705.64%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Global Report · Supply Tightness, Mexico Deal Signal Shift in Hong Kong Niche Sectors
Global Report · Hong Kong Mid-Caps Deploy Capital Tactics: Special Dividends, Themed Cruises and Strategic Shifts
Global Report · Vietnam's FTSE Upgrade Unlocks Billions. Hong Kong Offers Two Ways In.
Global Report · Auto Glass Spinoff Looms as Hong Kong Firms Pivot Through Market Shifts
Global Report · The Digital Pivot: How Hong Kong’s Legacy Assets Are Rewriting Their Survival Codes
Global Report · The Hong Kong Clearance Bin: Who's Trying and Who's Asleep
